Curoverse
Boston
About Curoverse
Curoverse employs open-source software to offer management, computation, and sharing services for genomic and biomedical data. At its core, Curoverse uses a free and open-source system called Arvados that was first developed for the Harvard Personal Genome Project. Arvados is designed to address the unique data management, computation, and sharing requirements are driven by genomic and biomedical data.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $1.5M
- Funding stage: M&A
- Last round: Series Unknown (Dec 2015)
- Website: curoverse.com
- Phone: 6175004134
Industries & Categories
Enterprise Software, Medical, Open Source, Software
Social Profiles
Canonical: https://fsome.com/organization/curoverse-2900102 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.